Replies to post #170138 on Vivos Inc (RDGL)

[doccjc]

Ask your boss .

[HoneyBager]

Because it’s not about what the share price is now. It’s about the increased strength in which the IDE is approved because of BDD backing. Share price will follow as progression is made for submitting IDE then again after approval

Many others on here repeat garbage yet it remains so diluting the garbage with actual facts helps retain and attract new investors.

[doccjc]

Someone say fastrack! One of only 20 odd radiology devices to be granted a BDD...ever. let that sink in people.

The FDA and the Mayo Clinic know how good Radiogel is.

For those who haven’t heard, this is BIG news for our fourth quarter of 2023, another step closer! #cancertherapy #radiogel #breakthroughstatus #humantrials #nextgeneration #isopet #vivosinc #perserverance $RDGL pic.twitter.com/EcPvlMneAn

— Vivos Inc. (@VivosIncUSA) January 24, 2024

[chereb19]

Breakthrough Device Designation


For those who haven’t heard, this is BIG news for our fourth quarter of 2023, another step closer! #cancertherapy #radiogel #breakthroughstatus #humantrials #nextgeneration #isopet #vivosinc #perserverance $RDGL pic.twitter.com/EcPvlMneAn

— Vivos Inc. (@VivosIncUSA) January 24, 2024